Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis
Posaconazole prophylaxis has proven highly effective in preventing invasive fungal infections, despite relatively low serum concentrations. However, high tissue levels of this agent have been reported in treated patients. We therefore hypothesized that the intracellular levels of antifungal agents a...
Gespeichert in:
Veröffentlicht in: | Antimicrobial Agents and Chemotherapy 2011-12, Vol.55 (12), p.5732-5739 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 5739 |
---|---|
container_issue | 12 |
container_start_page | 5732 |
container_title | Antimicrobial Agents and Chemotherapy |
container_volume | 55 |
creator | Campoli, P Al Abdallah, Q Robitaille, R Solis, N. V Fielhaber, J. A Kristof, A. S Laverdiere, M Filler, S. G Sheppard, D. C |
description | Posaconazole prophylaxis has proven highly effective in preventing invasive fungal infections, despite relatively low serum concentrations. However, high tissue levels of this agent have been reported in treated patients. We therefore hypothesized that the intracellular levels of antifungal agents are an important factor in determining the success of fungal prophylaxis. To examine the effect of host cell-associated antifungals on the growth of medically important molds, we exposed cells to antifungal agents and removed the extracellular drug prior to infection. Epithelial cells loaded with posaconazole and its parent molecule itraconazole, but not other antifungals, were able to inhibit fungal growth for at least 48 h and were protected from damage caused by infection. Cell-associated posaconazole levels were 40- to 50-fold higher than extracellular levels, and the drug was predominantly detected in cellular membranes. Fungistatic levels of posaconazole persisted within epithelial cells for up to 48 h. Therefore, the concentration of posaconazole in mammalian host cell membranes mediates its efficacy in prophylactic regimens and likely explains the observed discrepancy between serum antifungal levels and efficacy. |
doi_str_mv | 10.1128/AAC.00637-11 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_fao_a</sourceid><recordid>TN_cdi_pubmed_primary_21930891</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21930891</sourcerecordid><originalsourceid>FETCH-LOGICAL-a498t-836ddcf06599159f1a6566639bf0fd87fc27349ba397ca7340f72653c733f8773</originalsourceid><addsrcrecordid>eNp1kk1vEzEQhi0EoiFw4wwWEgcktvhj7V1zQIqi0iIVqAQ9WxPH3nW1sSN705B_j8OWAgdO9ngevzPz2gg9p-SUUta-WyyWp4RI3lSUPkAzSlRbSaHkQzQrx7KqW1KfoCc535ASC0UeoxNGFSetojOUlzEYG8YEo48BR4cXYfRuFzoY8KIrmYz3fux9wBcxj3hphwF_tptVgmDzewz4i93jK0iw9t0Gn8dbm4IPHR57i8-c8wbM4Sh7leK2Pwzww-en6JGDIdtnd-scXX88-768qC6_nn9aLi4rqFU7Vi2X67Vxx54VFcpRkEJKydXKEbduG2dYw2u1Aq4aA2VLXMOk4Kbh3LVNw-fow6S73a02dj2NOeht8htIBx3B638zwfe6i7eaM86aUmmO3k4CJsWck3X3dynRR_N1MV__Mr-EBX8z4ZA3TN_EXQplvP-xL_7u7V7498sU4PUdANnA4Irfxuc_nGCC1-zY46uJ633X732yulTXAEYLoSnToinTzNHLCXIQNXSpCF1_Y4QKcvwTdS35T4Z6rlo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Campoli, P ; Al Abdallah, Q ; Robitaille, R ; Solis, N. V ; Fielhaber, J. A ; Kristof, A. S ; Laverdiere, M ; Filler, S. G ; Sheppard, D. C</creator><creatorcontrib>Campoli, P ; Al Abdallah, Q ; Robitaille, R ; Solis, N. V ; Fielhaber, J. A ; Kristof, A. S ; Laverdiere, M ; Filler, S. G ; Sheppard, D. C</creatorcontrib><description>Posaconazole prophylaxis has proven highly effective in preventing invasive fungal infections, despite relatively low serum concentrations. However, high tissue levels of this agent have been reported in treated patients. We therefore hypothesized that the intracellular levels of antifungal agents are an important factor in determining the success of fungal prophylaxis. To examine the effect of host cell-associated antifungals on the growth of medically important molds, we exposed cells to antifungal agents and removed the extracellular drug prior to infection. Epithelial cells loaded with posaconazole and its parent molecule itraconazole, but not other antifungals, were able to inhibit fungal growth for at least 48 h and were protected from damage caused by infection. Cell-associated posaconazole levels were 40- to 50-fold higher than extracellular levels, and the drug was predominantly detected in cellular membranes. Fungistatic levels of posaconazole persisted within epithelial cells for up to 48 h. Therefore, the concentration of posaconazole in mammalian host cell membranes mediates its efficacy in prophylactic regimens and likely explains the observed discrepancy between serum antifungal levels and efficacy.</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.00637-11</identifier><identifier>PMID: 21930891</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antifungal Agents ; Antifungal Agents - pharmacokinetics ; Antifungal Agents - pharmacology ; Aspergillus fumigatus ; Aspergillus fumigatus - drug effects ; Aspergillus fumigatus - growth & development ; Biological and medical sciences ; blood serum ; Cell Line ; Cell Membrane ; Cell Membrane - metabolism ; cell membranes ; Chemoprevention ; disease control ; Epithelial Cells ; Epithelial Cells - metabolism ; Epithelial Cells - microbiology ; fungi ; host-pathogen relationships ; Humans ; itraconazole ; Itraconazole - pharmacokinetics ; Itraconazole - pharmacology ; Lung - cytology ; Macrophages ; Macrophages - metabolism ; Macrophages - microbiology ; mammals ; Medical sciences ; microbial growth ; Mycoses ; Mycoses - prevention & control ; patients ; Pharmacology ; Pharmacology. Drug treatments ; Triazoles ; Triazoles - pharmacokinetics ; Triazoles - pharmacology</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2011-12, Vol.55 (12), p.5732-5739</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011, American Society for Microbiology. All Rights Reserved.</rights><rights>Copyright © 2011, American Society for Microbiology. All Rights Reserved. 2011 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a498t-836ddcf06599159f1a6566639bf0fd87fc27349ba397ca7340f72653c733f8773</citedby><cites>FETCH-LOGICAL-a498t-836ddcf06599159f1a6566639bf0fd87fc27349ba397ca7340f72653c733f8773</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232766/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232766/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25253426$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21930891$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Campoli, P</creatorcontrib><creatorcontrib>Al Abdallah, Q</creatorcontrib><creatorcontrib>Robitaille, R</creatorcontrib><creatorcontrib>Solis, N. V</creatorcontrib><creatorcontrib>Fielhaber, J. A</creatorcontrib><creatorcontrib>Kristof, A. S</creatorcontrib><creatorcontrib>Laverdiere, M</creatorcontrib><creatorcontrib>Filler, S. G</creatorcontrib><creatorcontrib>Sheppard, D. C</creatorcontrib><title>Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Posaconazole prophylaxis has proven highly effective in preventing invasive fungal infections, despite relatively low serum concentrations. However, high tissue levels of this agent have been reported in treated patients. We therefore hypothesized that the intracellular levels of antifungal agents are an important factor in determining the success of fungal prophylaxis. To examine the effect of host cell-associated antifungals on the growth of medically important molds, we exposed cells to antifungal agents and removed the extracellular drug prior to infection. Epithelial cells loaded with posaconazole and its parent molecule itraconazole, but not other antifungals, were able to inhibit fungal growth for at least 48 h and were protected from damage caused by infection. Cell-associated posaconazole levels were 40- to 50-fold higher than extracellular levels, and the drug was predominantly detected in cellular membranes. Fungistatic levels of posaconazole persisted within epithelial cells for up to 48 h. Therefore, the concentration of posaconazole in mammalian host cell membranes mediates its efficacy in prophylactic regimens and likely explains the observed discrepancy between serum antifungal levels and efficacy.</description><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antifungal Agents</subject><subject>Antifungal Agents - pharmacokinetics</subject><subject>Antifungal Agents - pharmacology</subject><subject>Aspergillus fumigatus</subject><subject>Aspergillus fumigatus - drug effects</subject><subject>Aspergillus fumigatus - growth & development</subject><subject>Biological and medical sciences</subject><subject>blood serum</subject><subject>Cell Line</subject><subject>Cell Membrane</subject><subject>Cell Membrane - metabolism</subject><subject>cell membranes</subject><subject>Chemoprevention</subject><subject>disease control</subject><subject>Epithelial Cells</subject><subject>Epithelial Cells - metabolism</subject><subject>Epithelial Cells - microbiology</subject><subject>fungi</subject><subject>host-pathogen relationships</subject><subject>Humans</subject><subject>itraconazole</subject><subject>Itraconazole - pharmacokinetics</subject><subject>Itraconazole - pharmacology</subject><subject>Lung - cytology</subject><subject>Macrophages</subject><subject>Macrophages - metabolism</subject><subject>Macrophages - microbiology</subject><subject>mammals</subject><subject>Medical sciences</subject><subject>microbial growth</subject><subject>Mycoses</subject><subject>Mycoses - prevention & control</subject><subject>patients</subject><subject>Pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Triazoles</subject><subject>Triazoles - pharmacokinetics</subject><subject>Triazoles - pharmacology</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kk1vEzEQhi0EoiFw4wwWEgcktvhj7V1zQIqi0iIVqAQ9WxPH3nW1sSN705B_j8OWAgdO9ngevzPz2gg9p-SUUta-WyyWp4RI3lSUPkAzSlRbSaHkQzQrx7KqW1KfoCc535ASC0UeoxNGFSetojOUlzEYG8YEo48BR4cXYfRuFzoY8KIrmYz3fux9wBcxj3hphwF_tptVgmDzewz4i93jK0iw9t0Gn8dbm4IPHR57i8-c8wbM4Sh7leK2Pwzww-en6JGDIdtnd-scXX88-768qC6_nn9aLi4rqFU7Vi2X67Vxx54VFcpRkEJKydXKEbduG2dYw2u1Aq4aA2VLXMOk4Kbh3LVNw-fow6S73a02dj2NOeht8htIBx3B638zwfe6i7eaM86aUmmO3k4CJsWck3X3dynRR_N1MV__Mr-EBX8z4ZA3TN_EXQplvP-xL_7u7V7498sU4PUdANnA4Irfxuc_nGCC1-zY46uJ633X732yulTXAEYLoSnToinTzNHLCXIQNXSpCF1_Y4QKcvwTdS35T4Z6rlo</recordid><startdate>20111201</startdate><enddate>20111201</enddate><creator>Campoli, P</creator><creator>Al Abdallah, Q</creator><creator>Robitaille, R</creator><creator>Solis, N. V</creator><creator>Fielhaber, J. A</creator><creator>Kristof, A. S</creator><creator>Laverdiere, M</creator><creator>Filler, S. G</creator><creator>Sheppard, D. C</creator><general>American Society for Microbiology</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20111201</creationdate><title>Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis</title><author>Campoli, P ; Al Abdallah, Q ; Robitaille, R ; Solis, N. V ; Fielhaber, J. A ; Kristof, A. S ; Laverdiere, M ; Filler, S. G ; Sheppard, D. C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a498t-836ddcf06599159f1a6566639bf0fd87fc27349ba397ca7340f72653c733f8773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antifungal Agents</topic><topic>Antifungal Agents - pharmacokinetics</topic><topic>Antifungal Agents - pharmacology</topic><topic>Aspergillus fumigatus</topic><topic>Aspergillus fumigatus - drug effects</topic><topic>Aspergillus fumigatus - growth & development</topic><topic>Biological and medical sciences</topic><topic>blood serum</topic><topic>Cell Line</topic><topic>Cell Membrane</topic><topic>Cell Membrane - metabolism</topic><topic>cell membranes</topic><topic>Chemoprevention</topic><topic>disease control</topic><topic>Epithelial Cells</topic><topic>Epithelial Cells - metabolism</topic><topic>Epithelial Cells - microbiology</topic><topic>fungi</topic><topic>host-pathogen relationships</topic><topic>Humans</topic><topic>itraconazole</topic><topic>Itraconazole - pharmacokinetics</topic><topic>Itraconazole - pharmacology</topic><topic>Lung - cytology</topic><topic>Macrophages</topic><topic>Macrophages - metabolism</topic><topic>Macrophages - microbiology</topic><topic>mammals</topic><topic>Medical sciences</topic><topic>microbial growth</topic><topic>Mycoses</topic><topic>Mycoses - prevention & control</topic><topic>patients</topic><topic>Pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Triazoles</topic><topic>Triazoles - pharmacokinetics</topic><topic>Triazoles - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Campoli, P</creatorcontrib><creatorcontrib>Al Abdallah, Q</creatorcontrib><creatorcontrib>Robitaille, R</creatorcontrib><creatorcontrib>Solis, N. V</creatorcontrib><creatorcontrib>Fielhaber, J. A</creatorcontrib><creatorcontrib>Kristof, A. S</creatorcontrib><creatorcontrib>Laverdiere, M</creatorcontrib><creatorcontrib>Filler, S. G</creatorcontrib><creatorcontrib>Sheppard, D. C</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Campoli, P</au><au>Al Abdallah, Q</au><au>Robitaille, R</au><au>Solis, N. V</au><au>Fielhaber, J. A</au><au>Kristof, A. S</au><au>Laverdiere, M</au><au>Filler, S. G</au><au>Sheppard, D. C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2011-12-01</date><risdate>2011</risdate><volume>55</volume><issue>12</issue><spage>5732</spage><epage>5739</epage><pages>5732-5739</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Posaconazole prophylaxis has proven highly effective in preventing invasive fungal infections, despite relatively low serum concentrations. However, high tissue levels of this agent have been reported in treated patients. We therefore hypothesized that the intracellular levels of antifungal agents are an important factor in determining the success of fungal prophylaxis. To examine the effect of host cell-associated antifungals on the growth of medically important molds, we exposed cells to antifungal agents and removed the extracellular drug prior to infection. Epithelial cells loaded with posaconazole and its parent molecule itraconazole, but not other antifungals, were able to inhibit fungal growth for at least 48 h and were protected from damage caused by infection. Cell-associated posaconazole levels were 40- to 50-fold higher than extracellular levels, and the drug was predominantly detected in cellular membranes. Fungistatic levels of posaconazole persisted within epithelial cells for up to 48 h. Therefore, the concentration of posaconazole in mammalian host cell membranes mediates its efficacy in prophylactic regimens and likely explains the observed discrepancy between serum antifungal levels and efficacy.</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>21930891</pmid><doi>10.1128/AAC.00637-11</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0066-4804 |
ispartof | Antimicrobial Agents and Chemotherapy, 2011-12, Vol.55 (12), p.5732-5739 |
issn | 0066-4804 1098-6596 |
language | eng |
recordid | cdi_pubmed_primary_21930891 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Antibiotics. Antiinfectious agents. Antiparasitic agents Antifungal Agents Antifungal Agents - pharmacokinetics Antifungal Agents - pharmacology Aspergillus fumigatus Aspergillus fumigatus - drug effects Aspergillus fumigatus - growth & development Biological and medical sciences blood serum Cell Line Cell Membrane Cell Membrane - metabolism cell membranes Chemoprevention disease control Epithelial Cells Epithelial Cells - metabolism Epithelial Cells - microbiology fungi host-pathogen relationships Humans itraconazole Itraconazole - pharmacokinetics Itraconazole - pharmacology Lung - cytology Macrophages Macrophages - metabolism Macrophages - microbiology mammals Medical sciences microbial growth Mycoses Mycoses - prevention & control patients Pharmacology Pharmacology. Drug treatments Triazoles Triazoles - pharmacokinetics Triazoles - pharmacology |
title | Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T21%3A00%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_fao_a&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Concentration%20of%20Antifungal%20Agents%20within%20Host%20Cell%20Membranes:%20a%20New%20Paradigm%20Governing%20the%20Efficacy%20of%20Prophylaxis&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=Campoli,%20P&rft.date=2011-12-01&rft.volume=55&rft.issue=12&rft.spage=5732&rft.epage=5739&rft.pages=5732-5739&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.00637-11&rft_dat=%3Cpubmed_fao_a%3E21930891%3C/pubmed_fao_a%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/21930891&rfr_iscdi=true |